IceCure Medical (ICCM) Net Income (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Net Income data on file, last reported at -$4.3 million in Q1 2026.

• On a quarterly basis, Net Income fell 19.12% year-over-year to -$4.3 million in Q1 2026; TTM through Mar 2026 was -$15.7 million, a 2.92% decrease from a year earlier, with the FY2025 full-year figure at -$15.1 million, up 1.7% from the prior year.
• Net Income for Q1 2026 stood at -$4.3 million, down from -$4.2 million in the prior quarter.
• Over the last five years, Net Income for ICCM reached as high as -$3.0 million in Q4 2023 and fell as low as -$4.5 million in Q2 2022.
• Historically, Net Income has averaged -$3.9 million across 5 years, with a median of -$4.0 million in 2022.
• On a YoY basis, Net Income climbed as much as 61.65% in 2022 and fell as far as 224.36% in 2022.
• Year by year, Net Income stood at -$4.0 million in 2022, then increased by 24.22% to -$3.0 million in 2023, then plunged by 49.55% to -$4.5 million in 2024, then grew by 5.2% to -$4.2 million in 2025, then retreated by 0.66% to -$4.3 million in 2026.
• Per Business Quant data, the three most recent Net Income figures were -$4.3 million in Q1 2026, -$4.2 million in Q4 2025, and -$3.9 million in Q3 2025.